Fate Therapeutics Value At Risk
| FATE Stock | | | USD 1.16 0.01 0.87% |
This dataset for Fate Therapeutics reflects inputs used in the Value At Risk calculation. Values are derived from historical price and volume observations. Fate Therapeutics has a market cap of 133.7 M, operating margin of -24.56%, current ratio of 6.55. Portfolio-level context is available through
Investing Opportunities. Portfolio analysis tools can evaluate how Fate Therapeutics fits within a broader allocation. The information is presented without directional commentary. Broader economic conditions can influence Fate Therapeutics's company valuation — related indicators include
signals in population.
For more information on Fate Stock please use our
How to Invest in Fate Therapeutics overview. It covers the key aspects of trading Fate Stock.
Fate Therapeutics has current Value At Risk of
-7.63. Value At Risk (or VAR) is a statistical technique used to measure the level of financial risk of investment instrument over a specific time frame. It is a widely used measure of the risk of loss on a specific investing instrument.
Value At Risk | = | ER[a] x N | + | (Z-SCORE x STD x SQRT (N)) |
| = | -7.63 | |
| ER[a] | = | Expected return on investing in Fate Therapeutics |
| STD | = | Standard Deviation of Fate Therapeutics |
| N | = | Number of points for the period |
| Z-SCORE | = | Number of standard deviations above or below the mean |
Value At Risk Peers Comparison
Value At Risk Relative To Other Indicators
Fate Therapeutics is rated
below average for value at risk relative to top peers. It is currently under evaluation for maximum drawdown relative to top peers .
Value At Risk is used by risk managers in order to measure and control the level of risk which the firm undertakes. The risk manager job is to ensure that risks are not taken beyond the level at which the firm can absorb the losses of a probable worst outcome. VAR can be defined as the loss level that will not be exceeded with a certain confidence level during a certain period of time.
Compare Fate Therapeutics to Peers
Other Technical Indicators